American Thyroid Association

Thyroid® Journal – Editor-in-Chief Call for Applications
The ATA seeks applications for the next Editor-in-Chief of Thyroid®, the flagship journal, which just celebrated its 35th anniversary. Thyroid® is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid ca...

From Clinical Thyroidology® for the Public: Several options to treat Graves’ disease exist, including long term treatment with anti-thyroid medications, surgery to remove the thyroid and radioactive iodine therapy to destroy the thyroid. Recently, a technique known as radiofrequency ablation (RFA) has been used to treat hyperthyroidism in recurrent Graves’ disease. I...

Major Pharmaceuticals initiated a voluntary recall of its levothyroxine sodium tablets on July 13 after the Food and Drug Administration determined the pills were subpotent, meaning they deliver less medication than labeled.

Alexandria, VA — The American Thyroid Association® (ATA®) has been reaccredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians, extending its accredited status through 2030.

ACCME accreditation is a voluntary, peer-reviewed process that confirms an organization’s CME ac...

Nearly a decade has passed since the previous ATA guidelines were published in 2017, and a substantial body of new evidence has emerged that is reshaping how clinicians evaluate and manage thyroid disease before, during, and after pregnancy.

Drs Kaniksha Desai and Angela Leung discuss the newly released